Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · IEX Real-Time Price · USD

2.380

-0.170 (-6.67%)

At close: Jul 2, 2024, 4:00 PM

2.480

+0.100 (4.20%)

After-hours: Jul 2, 2024, 7:34 PM EDT

Cellectar Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2004
Net Income	-37.98	-28.6	-24.12	-15.09	-14.09	Upgrade
Depreciation & Amortization	0.25	0.24	0.23	0.21	0.19	Upgrade
Share-Based Compensation	2.41	1.45	1.12	0.47	0.87	Upgrade
Other Operating Activities	2.95	1.69	0.2	0.49	1.34	Upgrade
Operating Cash Flow	-32.38	-25.22	-22.57	-13.93	-11.69	Upgrade
Capital Expenditures	-0.86	-0.23	-0.14	-0.06	-0.02	Upgrade
Investing Cash Flow	-0.86	-0.23	-0.14	-0.06	-0.02	Upgrade
Share Issuance / Repurchase	0.79	0	1.25	60.36	9.02	Upgrade
Debt Issued / Paid	0	0	0	0.18	-0	Upgrade
Other Financing Activities	22.15	9.61	-	-	-	Upgrade
Financing Cash Flow	22.94	9.61	1.25	60.55	9.02	Upgrade
Net Cash Flow	-10.3	-15.84	-21.46	46.55	-2.7	Upgrade
Free Cash Flow	-33.24	-25.45	-22.71	-14	-11.72	Upgrade
Free Cash Flow Per Share	-2.72	-3.61	-4.09	-7.06	-15.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).